NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators in schizophrenia
- PMID: 1356142
- DOI: 10.1007/978-3-7091-9211-5_7
NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators in schizophrenia
Abstract
The monoaminergic innervation of the rat prefrontal cortex arises from well-defined mesencephalic nuclei, with noradrenergic (NE) neurons located in the locus coeruleus, dopaminergic (DA) neurons located in the ventral tegmental area, and serotonergic (5-HT) neurons originating in the raphe nuclei. Specific destruction of the NE bundle was found to induce morphological (i.e., sprouting) as well as metabolic (i.e., changes in rate of DA utilization) modifications of mesocortical DA neurons, suggesting that these two catecholaminergic systems have functional interactions within the prefrontal cortex. This was substantiated by experiments showing that DA afferents modulate the sensitivity of cortical post-synaptic beta-adrenergic receptors and that, reciprocally, NE neurons control the sensitivity of cortical D1 receptors. Behavioural and pharmacological data have further indicated that the stimulation of cortical alpha-1 adrenergic receptors inhibits cortical DA transmission at D1 receptors. Secondly, we have attempted to analyze how such interactions between neuromodulatory systems may be related to the development of mental diseases such as schizophrenia. On the basis of studies in the literature describing the effects produced by the ingestion of hallucinogenic drugs or data collected regarding REM sleep, it is postulated that two modes of brain functioning exist: analogical and cognitive. Each mode is characterized by differences in the relative activities of NE, DA and 5-HT neurons. At birth, during REM sleep, and following the ingestion of hallucinogens, the mode of brain functioning is essentially analogical; in contrast, both analogic and cognitive modes are postulated to coexist in the awake state. Oscillations between these two modes are under the control of monoaminergic systems on which an increase in cortical DA release favours the cognitive processing mode, whereas intermittent activations of NE neurons would switch the brain into the analogical mode of processing. It is proposed that schizophrenic patients with "positive" symptoms suffer from an abnormal preponderance of the analogical mode while awake, whereas "negative" symptoms are due to the excessive presence of the cognitive mode. Although pure biological deficits cannot be excluded, these dysfunctions could be related to the absence of particular environmental variables early in the development of these patients. This condition is probably required to establish normal regulatory control of monoaminergic neuronal activity.
Similar articles
-
Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.Int J Neuropsychopharmacol. 2011 Feb;14(1):53-68. doi: 10.1017/S1461145710000908. Epub 2010 Aug 12. Int J Neuropsychopharmacol. 2011. PMID: 20701825
-
New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons.Front Neural Circuits. 2014 May 21;8:53. doi: 10.3389/fncir.2014.00053. eCollection 2014. Front Neural Circuits. 2014. PMID: 24904299 Free PMC article. Review.
-
Noradrenergic Modulation of Dopamine Transmission Evoked by Electrical Stimulation of the Locus Coeruleus in the Rat Brain.ACS Chem Neurosci. 2017 Sep 20;8(9):1913-1924. doi: 10.1021/acschemneuro.7b00078. Epub 2017 Jun 21. ACS Chem Neurosci. 2017. PMID: 28594540
-
Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.Int J Neuropsychopharmacol. 2008 Aug;11(5):625-39. doi: 10.1017/S1461145707008383. Epub 2008 Jan 21. Int J Neuropsychopharmacol. 2008. PMID: 18205979
-
The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.Psychol Med. 1991 Nov;21(4):881-95. doi: 10.1017/s0033291700029871. Psychol Med. 1991. PMID: 1685791 Review.
Cited by
-
The effects of stress on central dopaminergic neurons: possible clinical implications.Neurochem Res. 1997 Nov;22(11):1387-94. doi: 10.1023/a:1022075324164. Neurochem Res. 1997. PMID: 9355111 Review.
-
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex.Front Pharmacol. 2020 Sep 23;11:588160. doi: 10.3389/fphar.2020.588160. eCollection 2020. Front Pharmacol. 2020. PMID: 33071798 Free PMC article.
-
The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?Naunyn Schmiedebergs Arch Pharmacol. 2004 Jun;369(6):629-38. doi: 10.1007/s00210-004-0929-2. Epub 2004 Apr 29. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15118809
-
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.Neurosci Biobehav Rev. 2009 Jul;33(7):981-1003. doi: 10.1016/j.neubiorev.2009.03.011. Epub 2009 Apr 1. Neurosci Biobehav Rev. 2009. PMID: 19580914 Free PMC article. Review.
-
Potential diagnostic biomarkers for schizophrenia.Med Rev (2021). 2022 Aug 2;2(4):385-416. doi: 10.1515/mr-2022-0009. eCollection 2022 Aug. Med Rev (2021). 2022. PMID: 37724326 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical